Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Aethlon Medical, Inc. is a clinical-stage medical device company focused on developing the Hemopurifier, an innovative immunotherapeutic device aimed at treating cancer, life-threatening viral infections, and organ transplantation. With a significant market opportunity, the Hemopurifier has received FDA designation as a Breakthrough Device for specific cancer and viral indications. Aethlon is expanding its clinical trials in Australia and India, addressing critical unmet medical needs through advanced technology.
This description was generated via AI from an annual report. Updated about 1 year ago.